Literature DB >> 17426030

Selective inhibition of the collagenase activity of cathepsin K.

Jana Selent1, Jadwiga Kaleta, Zhenqiang Li, Gilles Lalmanach, Dieter Brömme.   

Abstract

Cathepsin K, the main bone degrading protease, and chondroitin 4-sulfate (C4-S) form a complex with enhanced collagenase activity. In this report, we demonstrate the specific inhibition of the collagenase activity of cathepsin K by negatively charged polymers without affecting the overall proteolytic activity of the protease. Three different mechanisms to interfere with cathepsin-catalyzed collagen degradation are discussed: 1) inhibition of the formation of the cathepsin K/C4-S complex, 2) inhibition of the attachment of C4-S to collagen, and 3) masking of the collagenase cleavage sites in collagen. By targeting these interaction sites, collagen degradation can be modulated while the non-collagenolytic activities of cathepsin K remain intact. The main inhibitory effect on collagen degradation is due to the impeding effect on the active cathepsin K/C4-S complex. Essential structural elements in the inhibitor molecules are negative charges which compete with the sulfate groups of C4-S in the cathepsin K/C4-S complex. The inhibitory effect can be controlled by length and charge of the polymers. Longer negatively charged polymers (e.g. polyglutamates, oligonucleotides) tend to inhibit all three mechanisms, whereas shorter ones preferentially affect the cathepsin K/C4-S complex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17426030     DOI: 10.1074/jbc.M700242200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.

Authors:  Achilleas D Theocharis; Chrisostomi Gialeli; Panagiotis Bouris; Efstathia Giannopoulou; Spyros S Skandalis; Alexios J Aletras; Renato V Iozzo; Nikos K Karamanos
Journal:  FEBS J       Date:  2014-11-06       Impact factor: 5.542

2.  Structural basis of collagen fiber degradation by cathepsin K.

Authors:  Adeleke H Aguda; Preety Panwar; Xin Du; Nham T Nguyen; Gary D Brayer; Dieter Brömme
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

3.  Analysis of flavonoid-based pharmacophores that inhibit aggrecanases (ADAMTS-4 and ADAMTS-5) and matrix metalloproteinases through the use of topologically constrained peptide substrates.

Authors:  Mare Cudic; Gayle D Burstein; Gregg B Fields; Janelle Lauer-Fields
Journal:  Chem Biol Drug Des       Date:  2009-09-28       Impact factor: 2.817

4.  Excessive activity of cathepsin K is associated with cartilage defects in a zebrafish model of mucolipidosis II.

Authors:  Aaron C Petrey; Heather Flanagan-Steet; Steven Johnson; Xiang Fan; Mitche De la Rosa; Mark E Haskins; Alison V Nairn; Kelley W Moremen; Richard Steet
Journal:  Dis Model Mech       Date:  2011-11-01       Impact factor: 5.758

Review 5.  Cysteine cathepsins: from structure, function and regulation to new frontiers.

Authors:  Vito Turk; Veronika Stoka; Olga Vasiljeva; Miha Renko; Tao Sun; Boris Turk; Dušan Turk
Journal:  Biochim Biophys Acta       Date:  2011-10-12

6.  The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K.

Authors:  Elma Mons; Ineke D C Jansen; Jure Loboda; Bjorn R van Doodewaerd; Jill Hermans; Martijn Verdoes; Constant A A van Boeckel; Peter A van Veelen; Boris Turk; Dusan Turk; Huib Ovaa
Journal:  J Am Chem Soc       Date:  2019-02-14       Impact factor: 15.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.